CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells
about
Endoglin (CD105) as a urinary and serum marker of prostate cancerHighlights on endoglin (CD105): from basic findings towards clinical applications in human cancerAngiogenesis in male breast cancerBiology of renal tumour cancer stem cells applied in medicineA mutant receptor tyrosine phosphatase, CD148, causes defects in vascular developmentCell origin of human mesenchymal stem cells determines a different healing performance in cardiac regenerationInvestigation of endoglin wild-type and missense mutant protein heterodimerisation using fluorescence microscopy based IF, BiFC and FRET analyses.Multiple delivery of siRNA against endoglin into murine mammary adenocarcinoma prevents angiogenesis and delays tumor growthTransforming growth factor-β and the hallmarks of cancer.Tumor angiogenesis change estimated by using diffuse optical spectroscopic tomography: demonstrated correlation in women undergoing neoadjuvant chemotherapy for invasive breast cancer?Endoglin haplo-insufficiency modifies the inflammatory response in irradiated mouse hearts without affecting structural and mircovascular changes.Impact of source tissue and ex vivo expansion on the characterization of goat mesenchymal stem cells.Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.Gene Electrotransfer of Plasmid with Tissue Specific Promoter Encoding shRNA against Endoglin Exerts Antitumor Efficacy against Murine TS/A Tumors by Vascular Targeted Effects.Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment.Transcriptome analysis of cattle muscle identifies potential markers for skeletal muscle growth rate and major cell types.Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105.Molecular determinants of ovarian cancer plasticity.miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling.Endoglin regulates PI3-kinase/Akt trafficking and signaling to alter endothelial capillary stability during angiogenesis.Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers.CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells.Novel biochemical pathways of endoglin in vascular cell physiology.PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesisThe relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer.Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants.Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-β signaling pathways.Endoglin: a critical mediator of cardiovascular healthENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumoursEndoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cells.Identification of a gene expression profile associated with the regulation of angiogenesis in endometrial cancer.Balancing the activation state of the endothelium via two distinct TGF-beta type I receptorsEndoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.Effects of the combination of TRC105 and bevacizumab on endothelial cell biology.ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis.Endoglin - a marker of vascular endothelial cell proliferation in cancer.Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance.The roles of endoglin gene in cerebrovascular diseases.High expression of endoglin in primary breast cancer may predict response to neoadjuvant chemotherapy.Differences in proliferation rate between CADASIL and control vascular smooth muscle cells are related to increased TGFβ expression.
P2860
Q24314256-5AC5E1BC-B2F9-4CCC-9F90-591EC54E8723Q24798737-7FAF9DB3-8E7D-442B-B9E5-6F4BCABF5BA7Q24803467-3DCC752C-CF3E-48F4-A992-BC75F9AB907DQ27004622-D33E58D7-0609-4949-A99B-9C4743B5D6C7Q28508534-06B509C4-B2DD-45BE-BA85-D928AAD7B0B2Q33828642-ECEBEA97-7E37-410F-81BE-49586074C295Q33981941-B312BAD5-5FE9-4CC4-8FB0-201E51601672Q34672107-9915CEAF-7A80-43F9-8F22-1A359C5C71E9Q34789300-56C7E9A4-C8C7-4B24-B4F0-C0E0372AE538Q34811268-0C361F32-D2C3-4D3E-A35A-8AAB57A54F76Q34873610-7D99A660-0139-44E1-8ECB-33C4F9CEDE7EQ35245948-E2B0D4B2-BF7F-4A11-BF2D-1EC886A1E7C7Q35443250-A2BA6503-03AE-46D0-9C36-D192EAD887CFQ35536671-7075F262-BFCA-42FD-A47E-D786A160EDD7Q35552966-53169CCA-F33E-4B61-8F1B-68A580EB9539Q35607754-6FD29B98-7239-4F34-878D-C87F56928FFEQ35628653-717F43E6-A1E7-46D6-A4FA-99A15C029193Q35842085-CEDD7778-1B14-4B6C-9933-BC0F710ED36AQ35917632-76FC1DB8-4234-4B29-BF04-72B8BE5F997AQ36066614-6897556C-E647-47FB-B507-4D3644D67443Q36285676-65ADA4B6-F780-446B-BD45-CB41047D841AQ36320615-36F22638-E657-4BEE-B80E-C0C4772EDFA5Q36381160-D7A2CE37-DE91-4ED7-A542-F8DB24353C9AQ36473318-A34DD4FF-17FF-4720-86A7-D0D6CF9E6DDAQ36612601-4E57B6F3-5648-42BC-AB45-78AD53366D2AQ36756322-08385286-4D55-4E62-AE6A-269BDD926EAEQ36815716-1174873B-BC5E-4E10-AC41-023EA4300523Q36825271-7AFE7F95-A7C7-42C6-A69D-540173C76947Q37295765-08E634F0-390C-4FE1-ABA2-C2E3679AD05EQ37589238-E7DFCEF5-6615-4622-A43E-7360DDD73288Q38665853-F959D6CA-9620-492D-A604-7E7E78323BA0Q39646992-69E2FF85-7027-4047-98CD-FAAF64F7ABEDQ40251249-5B39FBA3-A0A3-48C1-9A4D-89D52F4C4D46Q41889215-BCF199B0-ADB7-4A18-8C43-FFC4C393EADFQ41896516-9441E851-CF3B-4603-9F5A-20804B1D0E28Q43121223-6CE10679-29EE-4677-BE07-B73CC1228666Q43211597-A6BDB951-B7BA-4386-897D-E9A05368F8B6Q46528698-F0427403-DB24-46CE-8585-F3ED7536F696Q49852158-959DC643-63B4-4F58-B465-F111B73D15D3Q51740449-9A9A6FD5-051F-4443-9EB2-6C14381980CF
P2860
CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells
description
im Januar 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 2000
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2000
@uk
name
CD105 antagonizes the inhibito ...... man vascular endothelial cells
@en
CD105 antagonizes the inhibito ...... man vascular endothelial cells
@nl
type
label
CD105 antagonizes the inhibito ...... man vascular endothelial cells
@en
CD105 antagonizes the inhibito ...... man vascular endothelial cells
@nl
prefLabel
CD105 antagonizes the inhibito ...... man vascular endothelial cells
@en
CD105 antagonizes the inhibito ...... man vascular endothelial cells
@nl
P2093
P356
P1433
P1476
CD105 antagonizes the inhibito ...... man vascular endothelial cells
@en
P2093
P356
10.1096/FASEBJ.14.1.55
P407
P577
2000-01-01T00:00:00Z